These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 35224630

  • 1. Population pharmacokinetics of piperacillin/tazobactam in critically ill Korean patients and the effects of extracorporeal membrane oxygenation.
    Kim YK, Kim HS, Park S, Kim HI, Lee SH, Lee DH.
    J Antimicrob Chemother; 2022 Apr 27; 77(5):1353-1364. PubMed ID: 35224630
    [Abstract] [Full Text] [Related]

  • 2. Population Pharmacokinetics and Dosing Optimization of Piperacillin-Tazobactam in Critically Ill Patients on Extracorporeal Membrane Oxygenation and the Influence of Concomitant Renal Replacement Therapy.
    Hahn J, Min KL, Kang S, Yang S, Park MS, Wi J, Chang MJ.
    Microbiol Spectr; 2021 Dec 22; 9(3):e0063321. PubMed ID: 34937189
    [Abstract] [Full Text] [Related]

  • 3. A pilot study on pharmacokinetic/pharmacodynamic target attainment in critically ill patients receiving piperacillin/tazobactam.
    Martínková J, Malbrain ML, Havel E, Šafránek P, Bezouška J, Kaška M.
    Anaesthesiol Intensive Ther; 2016 Dec 22; 48(1):23-8. PubMed ID: 26588478
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Continuous infusion of piperacillin-tazobactam significantly improves target attainment in children with cancer and fever.
    Maarbjerg SF, Thorsted A, Friberg LE, Nielsen EI, Wang M, Schrøder H, Albertsen BK.
    Cancer Rep (Hoboken); 2022 Oct 22; 5(10):e1585. PubMed ID: 34796702
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of piperacillin and tazobactam in critically Ill patients treated with continuous kidney replacement therapy: A mini-review and population pharmacokinetic analysis.
    Selig DJ, DeLuca JP, Chung KK, Pruskowski KA, Livezey JR, Nadeau RJ, Por ED, Akers KS.
    J Clin Pharm Ther; 2022 Aug 22; 47(8):1091-1102. PubMed ID: 35352374
    [Abstract] [Full Text] [Related]

  • 9. OTAC: Optimization of Antibiotic Therapy in Critically ill Patients. Using beta-lactam antibiotics by continuous infusion.
    Esteve-Pitarch E, Padullés-Zamora A, Maisterra-Santos K, Colom-Codina H, Cobo-Sacristán S.
    Farm Hosp; 2019 Sep 01; 43(5):151-157. PubMed ID: 31469627
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A Population Pharmacokinetics and Pharmacodynamic Approach To Optimize Tazobactam Activity in Critically Ill Patients.
    Kalaria SN, Gopalakrishnan M, Heil EL.
    Antimicrob Agents Chemother; 2020 Feb 21; 64(3):. PubMed ID: 31871076
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Piperacillin Population Pharmacokinetics and Dosing Regimen Optimization in Critically Ill Children with Normal and Augmented Renal Clearance.
    Béranger A, Benaboud S, Urien S, Moulin F, Bille E, Lesage F, Zheng Y, Genuini M, Gana I, Renolleau S, Hirt D, Tréluyer JM, Oualha M.
    Clin Pharmacokinet; 2019 Feb 21; 58(2):223-233. PubMed ID: 29862466
    [Abstract] [Full Text] [Related]

  • 16. Population pharmacokinetics and pharmacodynamics of piperacillin in critically ill patients during the early phase of sepsis.
    Sukarnjanaset W, Jaruratanasirikul S, Wattanavijitkul T.
    J Pharmacokinet Pharmacodyn; 2019 Jun 21; 46(3):251-261. PubMed ID: 30963365
    [Abstract] [Full Text] [Related]

  • 17. Population pharmacokinetics of piperacillin in febrile children receiving cancer chemotherapy: the impact of body weight and target on an optimal dosing regimen.
    Thorsted A, Kristoffersson AN, Maarbjerg SF, Schrøder H, Wang M, Brock B, Nielsen EI, Friberg LE.
    J Antimicrob Chemother; 2019 Oct 01; 74(10):2984-2993. PubMed ID: 31273375
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.